Internet Archive Scholar

MOESM2 of Epigenetic therapy of myelodysplastic syndromes connects to cellular differentiation independently of endogenous retroelement derepression

Anastasiya Kazachenka, George Young, Jan Attig, Chrysoula Kordella, Eleftheria Lamprianidou, Emmanuela Zoulia, George Vrachiolias, Menelaos Papoutselis, Elsa Bernard, Elli Papaemmanuil, Ioannis Kotsianidis, George Kassiotis
2019 Figshare  

Preserved Fulltext

fulltext thumbnail
Web Archive Capture PDF (4.4 MB)
https://web.archive.org/web/20200208145630/https://s3-eu-west-1.amazonaws.com/pstorage-npg-968563215/20412693/13073_2019_707_MOESM2_ESM.pdf

A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL. The file type is application/pdf.

Additional file 2: Figure S1. Gating strategy for cell sorting. Figure S2. Expression changes of selected individual EREs in CD34+ HSCs upon 5-AZA treatment. Figure S3. Expression changes of selected ERE families in CD34+ HSCs upon 5-AZA treatment. Figure S4. Lack of interferon signature in MDS and CMML HSCs cells in response to 5-AZA treatment. Figure S5. Expression of inflammation-related genes MDS and CMML HSCs cells in response to 5-AZA treatment. Figure S6. Elevated expression of ISGs and
more » ... RVs in healthy and untreated dysplastic HSCs. Figure S7. Survival probability in AML according to expression of the indicated prognostic transcripts. Figure S8. Structure of the treatment outcome-prognostic transcript CASC15.
doi:10.6084/m9.figshare.11447067 fatcat:7puerpwq3jgfpkcozuwlub4pwq
Open Access
Citation

Anastasiya Kazachenka, George Young, Jan Attig, Chrysoula Kordella, Eleftheria Lamprianidou, Emmanuela Zoulia, George Vrachiolias, Menelaos Papoutselis, Elsa Bernard, Elli Papaemmanuil, Ioannis Kotsianidis, George Kassiotis. "MOESM2 of Epigenetic therapy of myelodysplastic syndromes connects to cellular differentiation independently of endogenous retroelement derepression." Figshare (2019)